4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-20-005162
Chief Financial Officer sold 14,950 shares at $40.10 ($599,495)
- Chief Financial Officer acquired 3,259 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vasista Vittal Chief Financial Officer | 2020-07-15 | Option exercise | +3,259 | $13.09 | $42,660 | 209,974 | D: show line 1 in the form |
| Vasista Vittal Chief Financial Officer | 2020-07-15 | Sale | −14,950 | $40.10 | $599,495 | 195,024 | D: show line 2 in the form |
| Open-market sales · 14,950 sh · avg $40.10 · $599,495 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vasista Vittal Chief Financial Officer | 2020-07-15 | Option exercise · Employee Stock Option (Right to Buy) | −3,259 | 14,115 | D: show line 3 in the form |
Loading xslF345X03/primarydocument.xml…